Cargando…
Vaccine-Induced T-Cell and Antibody Responses at 12 Months after Full Vaccination Differ with Respect to Omicron Recognition
More than a year after the first vaccines against the novel SARS-CoV-2 were approved, many questions still remain about the long-term protection conferred by each vaccine. How long the effect lasts, how effective it is against variants of concern and whether further vaccinations will confer addition...
Autores principales: | Mai, Franz, Volzke, Johann, Reisinger, Emil C., Müller-Hilke, Brigitte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500953/ https://www.ncbi.nlm.nih.gov/pubmed/36146641 http://dx.doi.org/10.3390/vaccines10091563 |
Ejemplares similares
-
Higher SARS-CoV-2 Spike Binding Antibody Levels and Neutralization Capacity 6 Months after Heterologous Vaccination with AZD1222 and BNT162b2
por: Müller-Hilke, Brigitte, et al.
Publicado: (2022) -
Single-dose SARS-CoV-2 vaccinations with either BNT162b2 or AZD1222 induce disparate Th1 responses and IgA production
por: Müller, Michael, et al.
Publicado: (2022) -
A linear B-cell epitope close to the furin cleavage site within the S1 domain of SARS-CoV-2 Spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts
por: Lorenz, Peter, et al.
Publicado: (2023) -
Immunotherapy and vaccination against infectious diseases
por: Ebbers, Meinolf, et al.
Publicado: (2020) -
Distinguishing Incubation and Acute Disease Stages of Mild-to-Moderate COVID-19
por: Müller, Michael, et al.
Publicado: (2022)